Medtech conglomerate Olympus Corporation has finalized a definitive agreement to acquire implantable technology innovator BioProtect for a total consideration of... Read more
Tag: #M&A
CordenPharma acquires AmbioPharm, securing new peptide manufacturing hubs in the US and China
Amid an intensive capital mobilization program driving next-generation weight-loss manufacturing expansions, global contract development and manufacturing organization (CDMO) CordenPharma has... Read more
Pharmacity secures new funding from LeapFrog, targeting 500 new store openings over 3 years
Modern pharmacy retail chain Pharmacity has finalized a definitive funding round with international impact investor LeapFrog Investments, marking a new... Read more
Eli Lilly deploys nearly $4 billion to acquire three vaccine developers in infectious disease push
U.S. pharmaceutical heavyweight Eli Lilly has announced definitive agreements to purchase three clinical-stage vaccine developers in multi-lateral transactions valued at... Read more
Lantheus evaluates $7 billion buyout offer from Curium amid radiopharmaceutical sector boom
The global life sciences ecosystem is registering intensive consolidation momentum as Massachusetts-based Lantheus Holdings considers a multi-billion-dollar takeover proposal from... Read more
Tasco Pharma deploys over 200 billion VND to anchor major stake in Pharmedic amid eye drop product recall
The equity ownership architecture of Pharmedic Pharmaceutical Medicinal Joint Stock Company (Ticker: PMC) has undergone a major transition, with Tasco... Read more
Lantheus evaluates potential $7 billion buyout following acquisition proposal from Curium
Radiopharmaceutical specialist Lantheus Holdings is currently weighing a potential sale of the company after receiving a strategic takeover bid from... Read more
Jardine Matheson enters Australian healthcare sector via $2.4 billion acquisition of I-MED Radiology
Hong Kong-based multinational conglomerate Jardine Matheson has announced a definitive agreement to purchase a 100% equity stake in I-MED Radiology... Read more
Gilead Sciences expands oncology portfolio via $5 billion acquisition of Tubulis
Biopharmaceutical multinational Gilead Sciences has finalized the corporate acquisition of Tubulis GmbH, a privately held, Germany-based biotech entity operating at... Read more









